Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
Cancer organoids are 3D phenotypic cultures that can be established from resected or biopsy tumour samples and can be grown as mini tumours in the dish. Flourishing evidence supports the feasibility of patient derived organoids (PDO) from a number of solid tumours. Evidence for cholangiocarcinoma (C...
Main Authors: | Francesco Amato, Colin Rae, Maria Giuseppina Prete, Chiara Braconi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/4/832 |
Similar Items
-
Patient-Derived Organoids as a Model for Cancer Drug Discovery
by: Colin Rae, et al.
Published: (2021-03-01) -
Organoids and Colorectal Cancer
by: Antonio Barbáchano, et al.
Published: (2021-05-01) -
Patient-Derived Organoids of Cholangiocarcinoma
by: Christopher Fabian Maier, et al.
Published: (2021-08-01) -
Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses
by: Giulia Raimondi, et al.
Published: (2020-06-01) -
Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development
by: Sunrui Chen, et al.
Published: (2020-08-01)